Biocompatibility of nanoporous alumina membranes for immunoisolation

Biomaterials

Volumn 28, Issue 16, 2007, Pages 2638-2645

  La Flamme, Kristen E ^a   Popat, Ketul C ^b   Leoni, Lara ^c   Markiewicz, Erica ^c   La Tempa, Thomas J ^d   Roman, Brian B ^c   Grimes, Craig A ^d   Desai, Tejal A ^a,b  

^a Boston University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Alumina; Bioartificial pancreas; Biocompatibility; Cell encapsulation

Indexed keywords

ALUMINA; BIOCOMPATIBILITY; ENCAPSULATION; MEDICAL PROBLEMS; PATIENT TREATMENT; TISSUE;

BIOARTIFICIAL PANCREAS; CELL ENCAPSULATION; HOST TISSUES; NANOPOROUS ALUMINA MEMBRANES;

BIOLOGICAL MEMBRANES;

ALUMINUM OXIDE; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL ISOLATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY; HOST; IMMUNE RESPONSE; IMPLANTATION; INFLAMMATION; MALE; MEMBRANE; NONHUMAN; PERITONEAL CAVITY; POROSITY; PRIORITY JOURNAL; RAT; TISSUE REACTION;

ALUMINUM OXIDE; ANIMALS; CAPSULES; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; IMMUNOLOGIC TECHNIQUES; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; NANOSTRUCTURES; POLYETHYLENE GLYCOLS; RATS; SURFACE PROPERTIES;

RATTUS;

EID: 33847617058     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.02.010     Document Type: Article

References (39)

1. Chick W.L., et al. A hybird artifical pancreas. Trans Am Soc Artif Intern Organs 21 (1975) 8-15
2. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant 4 4 (1995) 415-436
3. Lanza R.P., and Chick W.L. Encapsulated cell therapy. Sci Am Sci Med 2 (1995) 16-25
4. Uludag H., De Vos P., and Tresco P.A. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 42 1-2 (2000) 29-64
5. Desai T.A., Hansford D., and Ferrari M. Characterization of micromachined silicon membranes for immunoisolation and bioseparation applications. J Memb Sci 159 (1999) 221-231
6. Figliuzzi M., et al. Subcutaneous xenotransplantation of bovine pancreatic islets. Biomaterials 26 28 (2005) 5640-5647
7. Yin C., et al. Microcapsules with improved mechanical stability for hepatocyte culture. Biomaterials 24 10 (2003) 1771-1780
8. Desai T.A., Hansford D.J., and Ferrari M. Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomol Eng 17 1 (2000) 23-36
9. Desai T.A., et al. Nanopore technology for biomedical applications. Biomed Microdevices 2 1 (1999) 11-40
10. Leoni L., Boiarski A., and Desai T.A. Characterization of nanoporous membranes for immunoisolation: diffusion properties and tissue effects. Biomed Microdevices 4 2 (2002) 131-139
11. Chen J., et al. Microencapsulation of islets in PEG-amine modified alginate-poly(l-lysine)-alginate microcapsules for constructing bioartificial pancreas. J Ferment Bioeng 86 2 (1998) 185-190
12. Orive G., et al. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials 27 20 (2006) 3691-3700
13. Thu B., et al. Alginate polycation microcapsules. II. Some functional properties. Biomaterials 17 11 (1996) 1069-1079
14. Desai T.A. MEMS-based technologies for cellular encapsulation: focus on nanopore biocapsules for diabetes mellitus therapy. Am J Drug Deliv 1 (2003) 3-11
15. Desai T.A., et al. Nanoporous microsystems for islet cell replacement. Adv Drug Deliv Rev 56 11 (2004) 1661-1673
16. Leoni L., and Desai T.A. Micromachined biocapsules for cell-based sensing and delivery. Adv Drug Deliv Rev 56 2 (2004) 211-229
17. Tao S.L., and Desai T.A. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 55 3 (2003) 315-328
18. Popat K.C., and Desai T.A. Poly(ethylene glycol) interfaces: an approach for enhanced performance of microfluidic systems. Biosens Bioelectron 19 9 (2004) 1037-1044
19. Popat K.C., et al. Surface modification of nanoporous alumina surfaces with poly(ethylene glycol). Langmuir 20 19 (2004) 8035-8041
20. Galindo M.L., et al. Long-term clinical results with Procera AllCeram full-ceramic crowns. Schweiz Monatsschr Zahnmed 116 8 (2006) 804-809
21. Morel X., et al. Biocompatibility of a porous alumina orbital implant. Preliminary results of an animal experiment. J Fr Ophtalmol 21 3 (1998) 163-169
22. Popat K.C., et al. Influence of nanoporous alumina membranes on long-term osteoblast response. Biomaterials 26 22 (2005) 4516-4522
23. Swan E.E., Popat K.C., and Desai T.A. Peptide-immobilized nanoporous alumina membranes for enhanced osteoblast adhesion. Biomaterials 26 14 (2005) 1969-1976
24. La Flamme K.E., et al. Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility. Diabetes Technol Ther 7 5 (2005) 684-694
25. Gong D., et al. Controlled molecular release using nanoporous alumina capsules. Biomed Microdev 5 (2003) 75-80
26. Itoh N., et al. Strengthened porous alumina membrane tube prepared by means of internal anodic oxidation. Microporous Mesoporous Mater 20 4-6 (1998) 333-337
27. Anderson J.M. Inflammatory response to implants. ASAIO Trans 34 2 (1988) 101-107
28. Anderson J.M. Biological responses to materials. Annu Rev Mater Res 31 (2001) 81-110
29. Anderson J.M., et al. Host reactions to biomaterials and their evaluation. In: Ratner B.D. (Ed). Biomaterials. 2nd ed (1996), Academic Press, San Diego 293-303
30. Neumann A., et al. Comparative investigation of the biocompatibility of various silicon nitride ceramic qualities in vitro. J Mater Sci Mater Med 15 10 (2004) 1135-1140
31. Van Tienhoven E.A., et al. In vitro and in vivo (cyto)toxicity assays using PVC and LDPE as model materials. J Biomed Mater Res A 78 1 (2006) 175-182
32. Zhang M., Desai T., and Ferrari M. Proteins and cells on PEG immobilized silicon surfaces. Biomaterials 19 10 (1998) 953-960
33. Nilsson B., et al. The role of complement in biomaterial-induced inflammation. Mol Immunol 44 1-3 (2007) 82-94
34. Bosetti M., et al. In vitro evaluation of the inflammatory activity of ultra-high molecular weight polyethylene. Biomaterials 24 8 (2003) 1419-1426
35. Madani F., et al. PEGylation of microspheres for therapeutic embolization: preparation, characterization and biological performance evaluation. Biomaterials 28 6 (2007) 1198-1208
36. Murakami Y., et al. Interaction of poly(styrene sulfonic acid) with the alternative pathway of the serum complement system. J Biomater Sci Polym Ed 16 3 (2005) 381-395
37. Sandeman S.R., et al. Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis. Biomaterials 26 34 (2005) 7124-7131
38. Duckworth W.C., Saudek C.D., and Henry R.R. Why intraperitoneal delivery of insulin with implantable pumps in NIDDM?. Diabetes 41 6 (1992) 657-661
39. Udelsman R., et al. Intraperitoneal delivery of insulin via mechanical pump: surgical implications. Langenbecks Arch Surg 385 6 (2000) 367-372